Skip to main content
. Author manuscript; available in PMC: 2012 Aug 8.
Published in final edited form as: Int J Geriatr Psychiatry. 2011 Jun;26(6):573–583. doi: 10.1002/gps.2565

Figure 2.

Figure 2

Treatment effect estimates (sertraline vs. placebo) for mADCS-CGIC in subgroups of patients meeting depression criteria at baseline (Odds ratio* [OR] and 95% CI)

*OR is the odds ratios (calculated using proportional odds logistic regression) of being at or better than a given mADCS-CGIC category for sertraline vs. placebo.